GeneQuantum Healthcare, a Chinese high-tech company focused on the research and development of innovative bio-therapeutics, announced on Wednesday that it has raised nearly RMB100 million (US$14.76 million) in a pre-B round of financing led by private equity firm Huagai Capital. China’s Hofon Capital, Changjin Boya, and returning investors including venture capital fund Oriza Seed Venture […] Chinese PE Firm Huagai Capital Leads $14M Fresh Round In Bio-Therapeutics Developer comes originally from China Money Network. All Rights Reserved.